RHEUMATOID ARTHRITIS DIAGNOSTIC TESTS MARKET ANALYSIS

Rheumatoid Arthritis Diagnostic Tests Market,Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (Serology Test (Erythrocyte Sedimentation Rate (ESR), Rheumatoid Factor (RF), Anti-cyclic Citrullinated Peptide (anti-CCP), Antinuclear Antibody (ANA), Uric Acid, Other Tests), Monitoring RA Treatment Efficiency Tests (Salicylate Level Count, Muscle Enzyme Tests (CPK, Aldolase), Creatinine Test)), By End User (Diagnostic Laboratories, Private Laboratories, Public Laboratories, Ambulatory Surgical Centers), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jun 2023
Code : CMI3716
Pages :165
Formats :
Excel and PDF
Industry : Clinical Diagnostic

Market News

Global Rheumatoid Arthritis Diagnostic Tests Market: Key Developments

In April 2022, Specialty Networks, LLC, a portfolio company of Linden Capital Partners is an integrated, multi-specialty organization with GPOs, Life Sciences, and Research solutions in U.S., announced the acquisition of United Rheumatology, LLC is the Rheumatology group purchasing organization (GPO) and real-world evidence (RWE) data & analytics company, community Rheumatology clinics will be able to maintain their independence while also improving the standard of treatment for patients.

In May 2021, the Arthritis Foundation is the nonprofit organization dedicated to the prevention control and cure of America's leading cause of rheumatoid arthritis, announced the launch of a application (Vim, the Arthritis Foundation's mobile app) and kicks off Arthritis Awareness with the release of key findings from a patient study.

In May 2022, United Rheumatology is the rheumatology care management organization empowering rheumatologists to advance the standard of care and CreakyJoints is a support, education, advocacy, and research organization for people living with arthritis and rheumatic disease, announced a partnership to develop the Rheumatoid Arthritis Wellness Center, a digital resource aimed at aiding those living with rheumatoid arthritis.

In September 2021, Labcorp is a life sciences company based in the U.S., announced that it has entered into a definitive agreement to acquire select operating assets and intellectual property (IP) from Myriad Genetics’ autoimmune business unit, including the Vectra rheumatoid arthritis (RA) assay.